NCT04971876View on ClinicalTrials.gov

Evaluation of the Safety and Performance of an Injectable Hyaluronic Acid Filler

NACompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

October 27, 2020

Primary Completion Date

August 11, 2022

Study Completion Date

September 6, 2022

Conditions
Lips EnhancementNasolabial Fold CorrectionMidface Volume Deficit
Interventions
DEVICE

HLR-1

Initial injection of HLR-1 and optional TU after 4 weeks. Maximum injection volume for each treatment session is 3mL.

DEVICE

HLR-2

Initial injection of HLR-2 and optional TU after 4 weeks. Maximum injection volume for each treatment session is 3mL per NLF.

DEVICE

HLR-3

Initial injection of HLR-3 and optional TU after 4 weeks. Maximum injection volume for each treatment session is 4mL per cheek.

Trial Locations (3)

40212

Private Practice Dr.Hilton & Partner GbR, Düsseldorf

Unknown

Rosenpark Research GmbH, Darmstadt

Centrum Medyczne Evimed, Warsaw

All Listed Sponsors
lead

Hallura Ltd.

INDUSTRY

NCT04971876 - Evaluation of the Safety and Performance of an Injectable Hyaluronic Acid Filler | Biotech Hunter | Biotech Hunter